Healthcare

Althea Group Holdings Limited (ASX:AGH)

Industry Group : Pharmaceuticals, Biotechnology & Life Sciences | Industry Group Name : Pharmaceuticals

Market Price : AUD 0.21-0.005 (2.326%)

(as on 2022-01-19 18:25:13 AEDT)

Market Cap : AUD 65.611 M

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
0.215 0.215 0.21 0.210L 0.215 H 0.210L 0.620 H
Last Trade 0.21
Change% -2.3256
52 W H/L 0.620/0.210
EBITDA -13.03 M
NPAT After Abnormal Items -15.046 M
Equity 42.696 M
ROE% -35.24%
Total Liabilities 11.216 M
Total Revenue 11.54 M
Cash and Cash Equivalents 6.388 M

Stock Information

Share price 0.21
Market Cap 65.611 M
Price/Gross Cash Flow -9.53
Dividend Yield Excluding Special 0.00%
Ending Shares 262.374 M
52-Week Range 0.620-0.210
P/E ratio 0.000
Sector P/E --
EPS -6.05
EV/EBITDA --
Net Profit Margin (%) -135.88%
Gross Cash Flows Per Share -0.03
Net Gearing -5.48%
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.09
Sales Per Share 0.04
Book Value Per Share 0.16

Announcements

Heading Date/Time
Notice of Annual General Meeting And Proxy Form  16/11/2021 5:52PM
Jobkeeper Payments  12/11/2021 5:14PM
Statement Pursuant to Listing Rule 4.7C.3  29/10/2021 5:27PM
Quarterly Activities/Appendix 4C Cash Flow Report  19/10/2021 8:21AM
Becoming a substantial holder  02/09/2021 5:07PM
Cleansing Notice  01/09/2021 9:42AM
Application for quotation of securities - AGH  01/09/2021 9:40AM
Peak Signs USD$3.42m Agreement With The Boston Beer Company  01/09/2021 8:19AM
Appendix 4G and Corporate Governance Statement  31/08/2021 8:45AM
Annual Report to Shareholders  31/08/2021 8:43AM
Response to ASX Query  30/08/2021 9:33AM
Proposed issue of securities - AGH  25/08/2021 9:37AM
AGH Successfully Raises $10.64m To Fuel Growth & Expansion  25/08/2021 9:37AM
Peak Signs With Canopy Growth Subsidiary and Trading Update  23/08/2021 8:43AM
Trading Halt  23/08/2021 8:32AM
Quarterly Activities/Appendix 4C Cash Flow Report  27/07/2021 8:46AM
Investor Presentation  27/07/2021 8:25AM
Peak signs CAD$1.25M contract with 48North Cannabis Corp  09/07/2021 9:08AM
Clarification Regarding ASX Announcement of 23 June 2021  25/06/2021 7:07PM
Althea Enters the USD$667M South African Cannabis Market  23/06/2021 8:33AM
Appendix 4C - quarterly  30/04/2021 8:18AM
Althea Launches Innovative Range of 20ml Flexi Products  29/03/2021 8:25AM
Updated - European Expansion and Strategic Growth Plan  15/03/2021 10:45AM
European Expansion and Strategic Growth  15/03/2021 8:24AM
Peak Receives First Order From Cronos Group  05/03/2021 9:13AM
Althea Reports 175% Revenue Growth For 1H FY2021  25/02/2021 9:22AM
Half Yearly Report and Accounts  25/02/2021 9:19AM
Peak Receives CAD$130K Initial Purchase Order From WeedMD  22/02/2021 8:27AM
Althea Completes First Shipment Of Products To Grow Pharma  11/02/2021 8:42AM

Similar Companies

Related Articles

Load More

About Company

ASX-listed global pharmaceutical company Althea Group Holdings Ltd (ASX:AGH) is a supplier of medicinal cannabis products to improve the lives of patients who are suffering from debilitating conditions. Althea is engaged in the production and export of pharmaceutical-grade medicinal cannabis. The Company also offers several services related to education, access, as well as management to support eligible patients & healthcare specialists in directing treatment pathways related to medicinal cannabis.

Corporate Information

company address Althea Company Pty Ltd, Suite 2, Level 37, 360 Elizabeth Street, MELBOURNE, VIC, AUSTRALIA, 3000

company phone+613 9427 7552

company websitehttp://www.althea.life 

Dividends

Year-end Date Franking DPS (AUD) Dividend Yield
30/06/2021 -- 0.000 0.00%
30/06/2020 -- 0.000 0.00%
30/06/2019 -- 0.000 0.00%
30/06/2018 -- 0.000 --

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2022-08-30 2022
Report (Prelim) 2022-08-30 2022
Report (Interim) 2022-02-24 2022

Financials

Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018
Trading Revenue 11.073 M 4.971 M 702,000 --
Other Revenue 467,000 91,000 65,000 0
Total Revenue 11.54 M 5.062 M 767,000 0
Interest Income 8,000 216,000 206,000 0
Interest Expenses -185,000 -704,000 -6,000 0
Expenses -24.395 M -18.494 M -9.594 M 0
EBITDA -12.855 M -13.432 M -8.827 M 0
Depreciation and Amortization -2.014 M -848,000 -48,000 0
Depreciation -1.413 M -488,000 -3,000 0
Amortisation -601,000 -360,000 -45,000 0
EBIT -14.869 M -14.28 M -8.875 M 0
Pre Tax Profit -15.046 M -14.768 M -8.675 M 0
Tax Expense 0 0 0 0
Net Profit After Tax -15.046 M -14.768 M -8.675 M 0
Minority Interest 0 0 0 0
Preference Dividend 0 0 0 0
Net Abnormal Items 0 0 0 0
Reported Net Profit After Abnormal Items -15.046 M -14.768 M -8.675 M 0
Ending Shares 262.374 M 233.31 M 203.31 M 131.72 M
Weighted Average Shares 248.682 M 230.062 M 169.62 M 131.72 M
EPS After Abnormal Items (cents) -6.05 -6.42 -5.11 0
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018
Total Current Assets 14.884 M 15.38 M 16.22 M 23.305 M
Total Non Current Assets 39.028 M 38.896 M 2.06 M 0
Total Assets 53.912 M 54.276 M 18.28 M 23.305 M
Total Current Liabilities 6.758 M 3.51 M 1.228 M 163,575
Total Non Current Liabilities 4.458 M 2.749 M 0 0
Total Liabilities 11.216 M 6.259 M 1.228 M 163,575
Net Assets 42.696 M 48.017 M 17.052 M 23.141 M
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018
Net Operating Cash -10.445 M -14.238 M -6.156 M 0
Net Invested Cash -2.403 M -14.139 M -1.671 M 0
Net Financing Cash Flows 9.182 M 23.773 M 20.489 M 0
Beginning Cash 10.143 M 14.918 M 2.3 M 0
End Cash Position 6.388 M 10.143 M 14.918 M 0
Exchange Rate Adjustments -89,000 -171,000 -44,000 0
Other Cash Adjustments 0 0 0 0
Ending Cash 6.388 M 10.143 M 14.918 M 0

© Morningstar, Inc. 2021. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the market indices, commodities and regulatory news headlines, and other data or content contained herein to be accurate, complete, or timely, and nor shall they have any liability for its use or distribution. The data contained herein: (1) is proprietary to Morningstar and/or its affiliates (collectively, “Morningstar”) and/or their content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Our publications, ratings and products should be viewed as an additional investment resource, and not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your financial situation, contact a professional financial adviser. Some material is copyrighted and published under licence from ASX Operations Pty. Ltd. ACN 004523782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK